406 related articles for article (PubMed ID: 33935070)
21. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.
Galassi M; Iavarone M; Rossi S; Bota S; Vavassori S; Rosa L; Leoni S; Venerandi L; Marinelli S; Sangiovanni A; Veronese L; Fraquelli M; Granito A; Golfieri R; Colombo M; Bolondi L; Piscaglia F
Liver Int; 2013 May; 33(5):771-9. PubMed ID: 23445369
[TBL] [Abstract][Full Text] [Related]
22. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
23. Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS.
Chen LD; Ruan SM; Lin Y; Liang JY; Shen SL; Hu HT; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
Eur Radiol; 2019 Aug; 29(8):4249-4257. PubMed ID: 30569182
[TBL] [Abstract][Full Text] [Related]
24. CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
van der Pol CB; McInnes MDF; Salameh JP; Levis B; Chernyak V; Sirlin CB; Bashir MR; Allen BC; Burke LMB; Choi JY; Choi SH; Forner A; Fraum TJ; Giamperoli A; Jiang H; Joo I; Kang Z; Kierans AS; Kang HJ; Khatri G; Kim JH; Kim MJ; Kim SY; Kim YY; Kwon H; Lee JM; Lewis SC; McGinty KA; Mulazzani L; Park MS; Piscaglia F; Podgórska J; Reiner CS; Ronot M; Rosiak G; Song B; Song JS; Tang A; Terzi E; Wang J; Wang W; Wilson SR; Yokoo T
Radiology; 2022 Feb; 302(2):326-335. PubMed ID: 34783596
[TBL] [Abstract][Full Text] [Related]
25. Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis.
Yang Y; Liu C; Yan J; Liu K
Abdom Radiol (NY); 2021 Oct; 46(10):4619-4628. PubMed ID: 34086090
[TBL] [Abstract][Full Text] [Related]
26. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
[TBL] [Abstract][Full Text] [Related]
27. Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Liu GJ; Wang W; Lu MD; Xie XY; Xu HX; Xu ZF; Chen LD; Wang Z; Liang JY; Huang Y; Li W; Liu JY
Liver Cancer; 2015 Dec; 4(4):241-52. PubMed ID: 26779444
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
29. Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study.
Meitner-Schellhaas B; Jesper D; Goertz RS; Zundler S; Strobel D
Clin Hemorheol Microcirc; 2023; 84(4):413-424. PubMed ID: 37334585
[TBL] [Abstract][Full Text] [Related]
30. Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound.
Chen LD; Xu HX; Xie XY; Xie XH; Xu ZF; Liu GJ; Wang Z; Lin MX; Lu MD
Eur Radiol; 2010 Mar; 20(3):743-53. PubMed ID: 19760416
[TBL] [Abstract][Full Text] [Related]
31. Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Fraquelli M; Nadarevic T; Colli A; Manzotti C; Giljaca V; Miletic D; Štimac D; Casazza G
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013483. PubMed ID: 36053210
[TBL] [Abstract][Full Text] [Related]
32. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
[TBL] [Abstract][Full Text] [Related]
33. Differentiating between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced MRI features: a systematic review and meta-analysis.
You MW; Yun SJ
Clin Radiol; 2019 May; 74(5):406.e9-406.e18. PubMed ID: 30704667
[TBL] [Abstract][Full Text] [Related]
34. Inter-reader reliability of contrast-enhanced ultrasound Liver Imaging Reporting and Data System: a meta-analysis.
Kang JH; Choi SH; Lee JS; Kim DW; Jang JK
Abdom Radiol (NY); 2021 Oct; 46(10):4671-4681. PubMed ID: 34156509
[TBL] [Abstract][Full Text] [Related]
35. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
Kang HJ; Lee JM; Yoon JH; Han JK
Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
[TBL] [Abstract][Full Text] [Related]
36. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
37. Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria.
Kang HJ; Lee JM; Yoon JH; Yoo J; Kim JH; Park J
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330156. PubMed ID: 37991335
[No Abstract] [Full Text] [Related]
38. Differential diagnosis between hepatic alveolar echinococcosis and intrahepatic cholangiocarcinoma with conventional ultrasound and contrast-enhanced ultrasound.
Wa ZC; Du T; Li XF; Xu HQ; Suo-Ang QC; Chen LD; Hu HT; Wang W; Lu MD
BMC Med Imaging; 2020 Aug; 20(1):101. PubMed ID: 32854653
[TBL] [Abstract][Full Text] [Related]
39. Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
Yang J; Huang JY; Chen X; Ling WW; Luo Y; Shi YJ; Liu JB; Lu Q; Lyshchik A
Eur Radiol; 2021 Aug; 31(8):6397-6405. PubMed ID: 33492470
[TBL] [Abstract][Full Text] [Related]
40. Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients.
Schellhaas B; Pfeifer L; Kielisch C; Goertz RS; Neurath MF; Strobel D
Ultraschall Med; 2018 Dec; 39(6):667-674. PubMed ID: 29879746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
